Stereotactic Radiosurgery or Other Local Ablation Then Erlotinib in Epidermal Growth Factor Receptor (EGFR)

NCT01573702 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

PROCEDURE: Stereotactic Radiosurgery
DRUG: Erlotinib

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

[object Object]